FDA Approves Tembexa

FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to […]

» Read more

FDA Approves Zynlonta

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE) APRIL 23, 2021 — ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. […]

» Read more


NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OSTEOVAN® Zoledronic acid Consumer Medicine Information What is in this leaflet This leaflet answers some common questions […]

» Read more
1 2 3 22